H.R. 2197
119th CONGRESS 1st Session
To prevent 340B covered entities from using savings derived for sex reassignment surgeries, hormonal therapies, and for other purposes.
IN THE HOUSE OF REPRESENTATIVES · March 18, 2025 · Sponsor: Mr. Johnson of South Dakota · Committee: Committee on Energy and Commerce
Table of contents
SEC. 1. Short title
- This Act may be cited as the No 340B Savings for Transgender Care Act.
SEC. 2. Prohibition on use of 340b savings for services described for transgender individuals
- (a) Prohibition on use of 340 savings for services described
- Section 340B(a)(4) of the Public Health Service Act () is amended by adding at the end the following: 42 U.S.C. 256b(a)(5)
- Prohibition on use of 340 savings for services described
- (E) Prohibition on use of 340b savings for services described
- A covered entity participating in the program under this section may not use any funds derived from the difference between the 340B ceiling price and the actual acquisition cost of covered outpatient drugs to pay for services described.
- (i) For purposes of this subsection—
- The term has the meaning given such term in section 340B(a)(4).
covered entities - The term means—
services described - sex reassignment surgeries furnished for the purpose of the gender alteration of a transgender individual; and
- hormone treatments furnished for the purpose of the gender alteration of a transgender individual.
- A covered entity participating in the program under this section may not use any funds derived from the difference between the 340B ceiling price and the actual acquisition cost of covered outpatient drugs to pay for services described.
- (E) Prohibition on use of 340b savings for services described